Which antipsychotic is approved for use in children aged 10 and older for acute mania?

Risperidone is the antipsychotic approved for use in children aged 10 and older for the treatment of acute mania associated with bipolar disorder. It has a well-established safety and efficacy profile for treating pediatric populations, particularly in cases of mood disorders.

Risperidone works by modulating various neurotransmitter systems, including dopamine and serotonin, which are believed to be involved in the pathophysiology of mania. As a second-generation antipsychotic, it is often preferred due to a more favorable side-effect profile compared to first-generation options.

While other medications may be used for mood stabilization, risperidone stands out specifically for its approval in this age group for acute mania. This approval is critical as it allows healthcare providers to address acute episodes effectively in younger patients, ensuring that they receive appropriate care during crucial developmental stages.